SOURCE: SECFilings.com

SECFilings.com

October 18, 2016 08:57 ET

SECFilings Releases Report on Why Bioelectronics are the Future of Medicine

REDONDO BEACH, CA--(Marketwired - Oct 18, 2016) -  SECFilings.com, a leading financial news and information portal offering free real time public filing alerts, recently published a report on the emerging bioelectronic medicine industry. In the report, the differences between pulsed electromagnetic fields (PEMF) and surgical implants are discussed, along with companies that have become innovators in both sides of the industry. Companies discussed in the report include Endonovo Therapeutics Inc. (OTCQB: ENDV), GlaxoSmithKline plc, and Alphabet Inc.'s Verily Life Science LLC.

Interested investors can read the full report here:
http://analysis.secfilings.com/articles/80-why-bioelectronics-are-the-future-of-medicine

About SECFilings.com

TDM Financial owns and operates web properties to educate investors and provide exposure for public companies. Our flagship web property, SECFilings.com, provides real-time SEC filing alerts to over 600,000 registered individuals, institutions, journalists, and other financial professionals. Through this property and others in our network, we have helped hundreds of companies build a sustainable base of shareholders through long-term educate-and-convert programs.

To sign-up for SEC filing e-mail and RSS alerts, visit www.secfilings.com, sign-up for a free account, and start following companies in your portfolio.

For more information about investor awareness solutions, please contact Daniel Minton at (406) 862-5400 or at dminton@tdmfinancial.com.

Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns SECFilings.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx.

Contact Information